These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 3245392

  • 21. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
    Pontiroli AE, Pizzocri P, Caumo A, Perseghin G, Luzi L.
    Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Factors responsible for development from normal glucose tolerance to isolated postchallenge hyperglycemia.
    Suzuki H, Fukushima M, Usami M, Ikeda M, Taniguchi A, Nakai Y, Matsuura T, Kuroe A, Yasuda K, Kurose T, Seino Y, Yamada Y.
    Diabetes Care; 2003 Apr; 26(4):1211-5. PubMed ID: 12663599
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.
    Yoshiuchi K, Matsuhisa M, Katakami N, Nakatani Y, Sakamoto K, Matsuoka T, Umayahara Y, Kosugi K, Kaneto H, Yamasaki Y, Hori M.
    Endocr J; 2008 Jul; 55(3):503-7. PubMed ID: 18445997
    [Abstract] [Full Text] [Related]

  • 27. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M, Georgianos PI, Didangelos T, Iliadis F, Makedou A, Hatzitolios A, Liakopoulos V, Grekas DM.
    Am J Nephrol; 2018 Jul; 47(1):21-29. PubMed ID: 29275415
    [Abstract] [Full Text] [Related]

  • 28. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y, Lu JM, Sun JF, Li CL, Wang XL, Zhang XQ, Lü ZH, Dou JT, Mu YM.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 17; 89(10):669-72. PubMed ID: 19595059
    [Abstract] [Full Text] [Related]

  • 29. Improvement in Neuropathy Outcomes With Normalizing HbA1c in Patients With Type 2 Diabetes.
    Ishibashi F, Taniguchi M, Kosaka A, Uetake H, Tavakoli M.
    Diabetes Care; 2019 Jan 17; 42(1):110-118. PubMed ID: 30455338
    [Abstract] [Full Text] [Related]

  • 30. Adiponectin and carotid intimal medial thickness in subjects with and without glucose intolerance (CURES-82).
    Gokulakrishnan K, Indulekha K, Ganesan S, Anuradha S, Mohan V.
    Diabetes Technol Ther; 2010 Feb 17; 12(2):109-15. PubMed ID: 20105040
    [Abstract] [Full Text] [Related]

  • 31. Impaired glucose tolerance in pancreas grafted diabetic patients is due to insulin secretory defects.
    Dieterle CD, Veitenhansl M, Gutt B, Arbogast H, Meier GR, Illner WD, Schlamp A, Seissler J, Landgraf R.
    Exp Clin Endocrinol Diabetes; 2007 Nov 17; 115(10):647-53. PubMed ID: 18058599
    [Abstract] [Full Text] [Related]

  • 32. One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose.
    Fiorentino TV, Marini MA, Andreozzi F, Arturi F, Succurro E, Perticone M, Sciacqua A, Hribal ML, Perticone F, Sesti G.
    J Clin Endocrinol Metab; 2015 Oct 17; 100(10):3744-51. PubMed ID: 26274345
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Serum glycerophosphate levels are increased in Japanese men with type 2 diabetes.
    Daimon M, Soga T, Hozawa A, Oizumi T, Kaino W, Takase K, Karasawa S, Jimbu Y, Wada K, Kameda W, Susa S, Kayama T, Saito K, Tomita M, Kato T.
    Intern Med; 2012 Oct 17; 51(6):545-51. PubMed ID: 22449660
    [Abstract] [Full Text] [Related]

  • 35. Insulin secretion and anti-GAD65 antibodies in subjects with impaired glucose tolerance.
    Tankova T, Dakovska L, Kirilov G, Koev D.
    Exp Clin Endocrinol Diabetes; 2001 Oct 17; 109(7):355-60. PubMed ID: 11573145
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Alanine-aminotransferase levels predict impaired glucose tolerance in a worksite population.
    Oberlinner C, Zober A, Nawroth PP, Humpert PM, Morcos M.
    Acta Diabetol; 2010 Jun 17; 47(2):161-5. PubMed ID: 19855923
    [Abstract] [Full Text] [Related]

  • 38. Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
    Haffner SM, Agil A, Mykkanen L, Stern MP, Jialal I.
    Diabetes Care; 1995 May 17; 18(5):646-53. PubMed ID: 8586002
    [Abstract] [Full Text] [Related]

  • 39. Low circulating vitamin D levels are associated with increased arterial stiffness in prediabetic subjects identified according to HbA1c.
    Zagami RM, Di Pino A, Urbano F, Piro S, Purrello F, Rabuazzo AM.
    Atherosclerosis; 2015 Dec 17; 243(2):395-401. PubMed ID: 26520892
    [Abstract] [Full Text] [Related]

  • 40. Glycosylated hemoglobins and glycosylated plasma proteins in the diagnosis of diabetes mellitus and impaired glucose tolerance.
    Hall PM, Cook JG, Sheldon J, Rutherford SM, Gould BJ.
    Diabetes Care; 1984 Dec 17; 7(2):147-50. PubMed ID: 6734381
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.